Management of hepatocellular carcinoma in Japan

Journal of Gastroenterology

Volumn 41, Issue 2, 2006, Pages 100-106

  Okita, Kiwamu ^a  

^a Shimonoseki Kohsei Hospital   (Japan)

Author keywords

Epidemiology; Hepatocellular carcinoma; High risk population; Management; Surveillance

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; DECARBOXYPROTHROMBIN;

ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER THERAPY; CHEMOEMBOLIZATION; CHRONIC DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; ECHOGRAPHY; GASTROINTESTINAL ENDOSCOPY; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HIGH RISK POPULATION; HUMAN; JAPAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN ANALYSIS; RADIOFREQUENCY ABLATION; REVIEW; RISK ASSESSMENT; SURGICAL TECHNIQUE; WORLD HEALTH ORGANIZATION;

CARCINOMA, HEPATOCELLULAR; HUMANS; JAPAN; LIVER NEOPLASMS;

EID: 33645286738     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-005-1763-0     Document Type: Review

References (33)

1. K Kiyosawa E Tanaka 2002 Characteristics of hepatocellular carcinoma in Japan Oncology 62 suppl 1 5-7 11868786
2. H Yoshizawa 2002 Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: Projection to other countries in the foreseeable future Oncology 62 suppl 1 8-17 11868791
3. AJ Sanyl 2002 AGA technical review on nonalcoholic fatty liver disease Gastroenterology 123 1705-25
4. AJ McCullough 2002 Update on nonalcoholic fatty liver disease J Clin Gastroenterol 34 255-62 10.1097/00004836-200203000-00013 11873108
5. J Bruix M Sherman 2005 Management of hepatocellular carcinoma Hepatology 42 1208-36 10.1002/hep.20933 16250051
6. El-Serag HB. Epidemiology of hepatocellular carcinoma in the United States. In: Abstracts of Fourth JSH Single Topic Conference on "Hepatocellular Carcinoma: International Consensus and Controversies," December 2-3, 2005, Awaji-island, Hyogo, Japan
7. JHG Wilson G Junguer 1968 The principles and practice of screening for disease. Public Health Papers 34 WHO Geneva
8. The Study Group for Production of the Guideline for Management of Hepatocellular Carcinoma Based upon a Scientific Base. Guideline for management of hepatocellular carcinoma based upon scientific evidence in 2005. Tokyo: Kanehara Shuppann; 2005 (in Japanese)
9. K Taketa Y Endo C Sekiya K Tanaikawa T Koji H Taga et al. 1993 A collaborative study for the evaluation of lectin-reactive alpha-fetoprotein in early detection of hepatocellular carcinoma Cancer Res 53 5419-23 1:CAS:528:DyaK2cXltFCjsg%3D%3D 7693340
10. K Izuno S Fujiyama K Yamasaki M Sato T Sato 1995 Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-gamma-carboxy prothrombin and alpha-fetoprotein: A prospective study Hepatogastroenterology 42 387-93 1:STN:280:BymC387kslE%3D 8586374
11. T Takayama M Makuuchi S Hirohashi M Sakamoto N Okazaki K Takayasu et al. 1990 Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma Lancet 336 1150-3 10.1016/0140-6736(90)92768-D 1:STN:280:By6D2c7islA%3D 1978027
12. K Okuda T Ohtsuki H Obata M Tomimatsu N Okazaki H Hasegawa et al. 1985 Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients Cancer (Phila) 56 918-28 1:STN:280:BiqB2MvivFE%3D
13. M Kudo H Chung Y Osaki 2003 Prognostic staging system for hepatocellular carcinoma (CLIP score): Its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score) J Gastroenterol 38 207-15 12673442
14. Liver Cancer Study Group of Japan 2003 General rules for the clinical and pathological study of primary liver cancer 2nd ed. Kanehara Tokyo
15. The Cancer of the Liver Italian Program (CLIP) investigators 1998 A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients Hepatology 28 751-5 10.1002/hep.510280322
16. X Calvert J Bruix P Gines C Bru M Sole R Vilana et al. 1990 Prognostic factors of hepatocellular carcinoma in the west: A multivariate analysis in 206 patients Hepatology 12 pt 1 753-60
17. R Yamada M Sato M Kawabata H Nakatsuka K Nakamura S Takashima et al. 1983 Hepatic artery embolization in 120 patients with unresectable hepatoma Radiology 148 2 397-401 1:STN:280:BiyB2cfht1Y%3D 6306721
18. H Kasugai J Kojima M Tatsuta S Okuda Y Sasaki et al. 1989 Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil Gastroenterology 97 965-71 1:STN:280:BiaA2sfmslE%3D 2550311
19. N Sugiura K Takahara M Ohto K Okuda N Hirooka 1983 Percutaneous intratumoral injection of ethanol under ultrasound imaging for treatment of small hepatocellular carcinoma (in Japanese) Acta Hepatol Jpn 24 920
20. T Seki M Wakabayashi T Nakagawa T Itoh T Shiro K Kunieda et al. 1994 Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma Cancer (Phila) 74 814-25
21. S Rossi F Fornari L Buscarini 1993 Percutaneous ultrasound guided radiofrequency electrocautery for the treatment of small hepatocellular carcinoma J Intervent Radiol 8 97-103
22. SM Lin CJ Lin CC Lin CW Hsu YC Chen 2004 Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < I = cm Gastroenterology 127 6 1714-23 10.1053/ j.gastro.2004.09.003 15578509
23. I Ikai S Arii T Ichida K Okita M Omata M Kojiro et al. 2005 Report of the 16th follow-up survey of primary liver cancer Hepatol Res 32 173-84
24. M Makuuchi H Hasegawa S Yamazaki 1985 Ultrasonically guided subsegmentectomy Surg Gynecol Obstet 161 346-50 1:STN:280:BimD3MbktVI%3D 2996162
25. K Takasaki 1998 Hepatic resection using glissonean pedicle transaction J Jpn Surg Soc 99 245-50 1:STN:280:DyaK1czgs1KlsA%3D%3D
26. S Iwatsuki RD Gordon BW Shaw Jr TE Starzl 1985 Role of liver transplantation in cancer therapy Ann Surg 202 401-7 1:STN:280:BimD38vkslU%3D 2996449
27. M Minagawa M Makuuchi T Takayama N Kokudo 2003 Selection criteria for repair hepatectomy in patients with recurrent hepatocellular carcinoma Ann Surg 238 703-10 14578733
28. A Kasahara N Hayashi K Mochizuki M Takayanagi K Yoshioka S Kakuma 1998 Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C Hepatology 27 1394-402 10.1002/hep.510270529 1:CAS:528:DyaK1cXjtVSjt7Y%3D 9581697
29. T Okanoue Y Itoh M Minami S Sakamoto K Yasui M Sakamoto 1999 Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C, but not significantly in advanced stage: A retrospective study in 1148 patients J Hepatol 30 653-9 10.1016/ S0168-8278(99)80196-2 1:CAS:528:DyaK1MXjtVWqsbo%3D 10207807
30. H Toyoda T Kumada S Nakano I Takeda K Sugiyama S Kiriyama 2001 Effect of the dose and duration of interferon-alpha therapy on the incidence of hepatocellular carcinoma in noncirrhotic patients with a nonsustained response to interferon for chronic hepatitis C Oncology 61 134-42 10.1159/000055364 1:CAS:528:DC%2BD3MXntFKjtL8%3D 11528252
31. Y Muto H Moriwaki M Ninomiya S Adachi A Saito KT Takasaki et al. 1996 Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma N Engl J Med 334 1561-7 10.1056/NEJM199606133342402 1:CAS:528:DyaK28XksVCgsLk%3D 8628336
32. Y Muto H Moriwaki A Saito 1999 Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma N Engl J Med 340 1046-7 10.1056/NEJM199904013401315 1:STN:280:DyaK1M7ot1agsw%3D%3D 10189289
33. D Habu S Shiomi A Tamon T Takeda T Tanaka S Kubo et al. 2004 Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver JAMA 29 3 358-61